Innovative Monitoring Lucid Scientific's flagship product, Resipher, offers unique real-time cell culture monitoring by measuring oxygen consumption, providing investors and partners with a cutting-edge solution that enhances research accuracy and efficiency.

Growing Funding With a recent Series A investment of $7 million led by IAG Capital Partners and a history of successful seed funding, the company has strong financial backing to expand its sales and market reach.

Industry Recognition Receiving a Gold Medal from Instrument Business Outlook highlights the company's innovative design and reliability, which can be leveraged in sales pitches to differentiate Resipher in a competitive biotech market.

Market Expansion Targeting biotech laboratories and research institutions globally, Lucid Scientific's growth in revenue and technological offerings presents opportunities to expand into larger research organizations and commercial labs.

Competitive Edge With a proprietary measurement technology and recent strategic hires including board members experienced in venture capital, Lucid Scientific is positioned as a forward-thinking company ripe for collaborations and large-scale deployments.